Kesin Pharma is expanding our portfolio of specialty pharmaceuticals.

Product Therapeutic Area Profile Estimated Launch Date
KSN-SP-001 Cardiovascular Oral liquid product that enhances ease of administration, patient convenience, and dosing compliance for chronic treatment Q2 2024
KSN-SP-002 Anti-Infective Oral liquid product that provides taste masking and dosage convenience Q2 2023